29.25BUSD
Type
Common Stock
Exchange
IL
Currency Code
USD
Currency Name
US Dollar
Country Name
UK
Country ISO
GB
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
5.91
PEG Ratio
0.05
Book Value
83.02
Dividend Share
-
Dividend Yield
-
Earnings Share
18
Wall Street Target Price
219.54
EPS Estimate Current Year
35.11
EPS Estimate Next Year
18.05
EPS Estimate Current Quarter
7.58
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
9,184,199,680
Gross Profit TTM
7,989,000,192
EBITDA
5,939,800,064
Profit Margin
47.64%
Return On Assets TTM
16.92%
Return On Equity TTM
23.82%
Revenue Per Share TTM
37.937
Qtly Revenue Growth YOY
-94.80%
Diluted Eps TTM
18
Qtly Earnings Growth YOY
-85.60%
Trailing PE
5.91
Forward PE
7
Price Sales TTM
3.1846
Price Book MRQ
1.1553
Enterprise Value Revenue
3
Enterprise Value EBITDA
110
1940.00
0.52%985.00
0.00%2600.00
0.00%202.50
-5.81%0.91
-2.67%127.20
-2.00%1.74
-1.60%118.50
-1.00%1404.00
-0.95%313.50
-0.16%